首页> 外文OA文献 >Comment on: ‘Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al

【2h】

Comment on: ‘Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al

机译：评论：'狼疮低疾病活动状态（LLDAS）达到判断在系统性红斑狼疮试验中判断响应者：埃里克·莫兰等人的IIB缪斯缪斯试验后的HOC分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
David Isenberg;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Comment on: ‘Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al [J] . David Isenberg Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2019,第11期

机译：评论：'狼疮低疾病活动状态（LLDAS）达到判断在Systemic Lupus红斑试验中判断响应者：Heacer MustAns的IIB缪斯缪斯试验后的HOC分析
2. Response to: ‘Comment on: ‘Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al’ by Isenberg [J] . Eric F Morand, Teodora Trasieva, Anna Berglind, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2019,第11期

机译：回应：'评论：'狼疮低疾病活动状态（LLDAS）达到判断在系统性红斑狼疮试验中的响应者：伊森伯格埃里克·莫兰等人的IIB缪斯试验后术后
3. Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab [J] . Morand Eric F., Trasieva Teodora, Berglind Anna, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第5期

机译：Lupus低疾病活动状态（LLDAS）达到判断在Systemic狼疮红斑试验中的响应者判断：HOC对ANIFROLUMAB的IIB MUSE试验的后HOC分析
4. Systemic Lupus Erythematosus manifestation using ID3 algorithm - A clinical analysis [C] . Gomathi S., Narayani V. 2014 International Conference on Data Mining and Intelligent Computing . 2014

机译：使用ID3算法的系统性红斑狼疮表现-临床分析
5. Investigation of the relationship between disease activity and disease damage in childhood-onset systemic lupus erythematosus. [D] . Brunner, Hermine Isabella. 2001

机译：儿童期系统性红斑狼疮疾病活动与疾病损害之间关系的研究。
6. Extended report: Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab [O] . Eric F Morand, Teodora Trasieva, Anna Berglind, -1

机译：扩展报告：系统性红斑狼疮试验中狼疮低病活动状态（LLDAS）的获得可区分反应者：对anifrolumab的IIb期MUSE试验的事后分析
7. Response to: ‘Comment on: ‘Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al’ by Isenberg [O] . Eric F Morand, Teodora Trasieva, Anna Berglind, 2018

机译：回应：'评论：'狼疮低疾病活动状态（LLDAS）达到判断患有系统性红斑狼疮试验的响应者：伊森伯格埃里克·莫兰等人AnifroLumab的阶段IIB缪斯试验后的术后分析

Comment on: ‘Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al

著录项

相似文献

相关主题

期刊订阅